Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Document › Details

Cellnovo. (7/6/17). "Press Release: Cellnovo Launches a Capital Increase for Approximately €15 Million [Not for Distribution in the United States of America, Canada, Australia and Japan]".

Organisations Organisation Cellnovo Group S.A. (Euronext: CLNV)
  Group Cellnovo (Group)
  Organisation 2 INSTITUTIONAL INVESTOR/S
  Group OTHER
Products Product Cellnovo Diabetes Management System
  Product 2 investment banking
Index term Index term Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors
Persons Person Baratte, Sophie (Cellnovo 201602 CEO)
  Person 2 Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Cellnovo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top